Luca Gambini

Partner
Industry contact for:
Luca Gambini handles venture capital transactions for investors and startups. His practice is complemented by his skills in cross-border acquisitions.”
CHAMBERS EUROPE 2024 – CORPORATE/M&A: MID-MARKET
Luca joined Portolano Cavallo in 2007 and he is a partner in the Firm’s Life Sciences and M&A practice groups since January 2018.

Luca is ranked by Chambers Europe 2024 for Corporate/M&A: Mid Market (Up and coming), by The Legal 500 EMEA 2024 as a “Next Generation Partner” for Healthcare and Life Sciences and by Who’s Who Legal as “Recommended” in the Life Sciences 2024 (“Transactional”), the M&A 2023 and the Italy 2023 (“Life Sciences”,  “M&A and Governance”) guides.

He focuses his practice in domestic and cross border M&Aprivate equity and venture capital transactions acting for investors and companies at all stages of development across the spectrum of life sciences and technology industries, including biotechnology, medical devices, pharmaceutical, and digital/information technology.

He has also gained a strong and extensive experience on commercial contracts for clients operating in the Life Sciences industries, including the drafting and negotiation of pharmaceutical products’ manufacturing, supply, distribution and co-marketing contracts, as well as clinical trials and proctoring agreements, and other commercial and IT agreements.

Luca contributes regularly to newsletters and journals on M&A and Life Sciences topics; he authored the articles “Pros And Cons of Earn-Out Construct in Life Sciences Merger and Acquisition Transactions” and “How to survive to financial crisis, political changes and other adverse events: an overview of MAC clauses in recent transactions with an in-depth analysis of the Abbott Laboratories/Alere Inc. case” (both articles published by Bocconi Legal Papers), and he co-authored the Italian chapter of The Life Sciences Law Review and contributed to the ABA European Private Target M&A Deal Points Study 2017.

He was involved in drafting the Italian version of the Subscription Agreement for Future Equity, or SAFE (Contratto di Sottoscrizione di Futuro Aumento di Capitale), an agreement template that founders and investors can use in early-stage investments in innovative companies.

Luca also contributed to the preparation of a sample term sheet for an A round investment and a glossary explaining the main issues and legal clauses in the context of an investment transaction, as well as observations, practical advice and best practices on issues frequently discussed and negotiated between the parties.

Prior to joining the firm he completed an internship with a law firm in Washington DC and he has been on secondment at the M&A and Private Equity department of Morrison & Foerster LLP in New York City, assisting some of the main US and Canadian private equity funds.

He graduated in 2006 from the Luiss Guido Carli of Rome.

Foreign languages: English

Luca is a member of the Rome Bar Association.

Luca is very helpful and has a strong sense of commercial issues. He was always available and very clear on any given deadlines."
CHAMBERS EUROPE 2023 – CORPORATE/M&A: MID-MARKET
The team, led by Elisa Stefanini and Luca Gambini, is particularly skilled."
LEGAL 500 EMEA 2023 - HEALTCHARE AND LIFE SCIENCES
Back
Follow us on